NASDAQ:KIDS • US68752L1008
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for ORTHOPEDIATRICS CORP (KIDS).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-03-02 | Truist Securities | Maintains | Hold -> Hold |
| 2026-02-27 | BTIG | Maintains | Buy -> Buy |
| 2026-02-27 | Needham | Maintains | Buy -> Buy |
| 2026-01-27 | TD Cowen | Initiate | Buy |
| 2025-12-10 | Canaccord Genuity | Initiate | Buy |
| 2025-10-29 | BTIG | Reiterate | Buy -> Buy |
| 2025-10-29 | Needham | Maintains | Buy -> Buy |
| 2025-10-10 | Lake Street | Maintains | Buy -> Buy |
| 2025-10-10 | BTIG | Maintains | Buy -> Buy |
| 2025-10-10 | JMP Securities | Maintains | Market Outperform -> Market Outperform |
| 2025-10-10 | Stifel | Maintains | Buy -> Buy |
| 2025-10-10 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2025-08-08 | JMP Securities | Maintains | Market Outperform -> Market Outperform |
| 2025-08-06 | BTIG | Maintains | Buy -> Buy |
| 2025-05-08 | Needham | Reiterate | Buy -> Buy |
| 2025-05-08 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2025-04-11 | Truist Securities | Maintains | Hold -> Hold |
| 2025-04-09 | Needham | Reiterate | Buy -> Buy |
| 2025-04-07 | Lake Street | Initiate | Buy |
| 2025-03-21 | Citizens Capital Markets | Reiterate | Market Outperform -> Market Outperform |
| 2025-03-05 | Needham | Reiterate | Buy -> Buy |
| 2025-03-05 | Stifel | Maintains | Buy -> Buy |
| 2025-01-14 | Needham | Reiterate | Buy -> Buy |
| 2024-12-18 | Truist Securities | Maintains | Hold -> Hold |
| 2024-11-08 | Needham | Reiterate | Buy -> Buy |
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 122.3M 24.80% | 148.732M 21.61% | 204.727M 37.65% | 239.38M 16.93% | 269.6M 12.62% | 301.55M 11.85% | 337.11M 11.79% | 376.07M 11.56% | 419.02M 11.42% | |
| EBITDA YoY % growth | -8.3M -21.70% | -8.381M -0.98% | -10.441M -24.58% | 16.479M 257.83% | 25.462M 54.51% | 37.34M 46.65% | 41.223M 10.40% | 59.874M 45.24% | 77.01M 28.62% | |
| EBIT YoY % growth | -21.4M -22.29% | -25.766M -20.40% | -29.521M -14.57% | -39.076M -32.37% | -24.082M 38.37% | -15.84M 34.22% | -32.143M -102.92% | N/A | N/A | |
| Operating Margin | -17.50% | -17.32% | -14.42% | -16.32% | -8.93% | -5.25% | -9.53% | N/A | N/A | |
| EPS YoY % growth | -0.91 -18.18% | -0.92 -1.32% | -1.63 -76.79% | -1.61 -3.68% | -1.16 31.26% | -0.77 33.93% | -1.40 -82.06% | -0.01 99.27% | 0.49 4,900.00% |
All data in USD
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.49 -5.58% | -0.29 3.44% | -0.23 53.08% | -0.26 39.22% | -0.29 41.12% | -0.24 17.72% | -0.20 13.04% | -0.41 -55.71% |
| Revenue Q2Q % growth | 59.482M 13.49% | 69.632M 14.00% | 70.45M 15.02% | 68.195M 10.70% | 67.728M 13.86% | 78.443M 12.65% | 78.831M 11.90% | 76.148M 11.66% |
| EBITDA Q2Q % growth | 931.903K 115.81% | 6.783M 167.89% | 9.889M -7.15% | 8.883M 40.84% | N/A | N/A | N/A | 38.454M 332.89% |
| EBIT Q2Q % growth | -9.918M 9.35% | -5.401M 29.72% | -3.498M 28.12% | -4.662M 32.05% | N/A | N/A | N/A | -18.564M -298.16% |
All data in USD
15 analysts have analysed KIDS and the average price target is 24.48 USD. This implies a price increase of 41.42% is expected in the next year compared to the current price of 17.31.
ORTHOPEDIATRICS CORP (KIDS) will report earnings on 2026-05-05, after the market close.
The consensus EPS estimate for the next earnings of ORTHOPEDIATRICS CORP (KIDS) is -0.49 USD and the consensus revenue estimate is 59.48M USD.
The consensus rating for ORTHOPEDIATRICS CORP (KIDS) is 82.6667 / 100 . This indicates that analysts generally have a positive outlook on the stock.